Belvedere Trading »

Tarsus Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2026-06-30 $271k 4.3k 62.94
2024-03-31 $502k 14k 36.35

More positions owned by Belvedere Trading

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Sandisk Corp (SNDK)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold SHS (GLD)
Intel Corporation (INTC)

View all positions for Belvedere Trading

Top funds holding Tarsus Pharmaceuticals

BlackRock
Deep Track Capital
Rtw Investments
Jupiter Topco
Paradigm Biocapital Advisors
Henderson Group
Morgan Stanley
Vanguard Capital Management
Jennison Associates
Tang Capital Management
Millennium Management
Bank of America Corporation
Geode Capital Management
Vestal Point Capital
State Street Corporation

View all funds holding Tarsus Pharmaceuticals